Maa: Australia
Kieli: englanti
Lähde: APVMA (Australian Pesticides and Veterinary Medicines Authority)
ATROPINE; ACEPROMAZINE
MAVLAB PTY. LTD.
acepromazine as maleate(1.488mg/mL)+atropine as sulfate(0.42mg/mL)
PARENTERAL LIQUID/SOLUTION/SUSPENSION
ATROPINE ALKALOID Active 0.42 mg/ml; ACEPROMAZINE THIAZOLE Active 1.488 mg/ml
100mL
VM - Veterinary Medicine
CAT | CATTLE | DOG | HORSE | PIGS | BEEF | BITCH | BOAR | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF |
CENTRAL NERVOUS SYSTEM
PRE-ANAESTHETIC | ANAESTHETIC PREMEDICANT
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [PRE-ANAESTHETIC]; CATTLE: [PRE-ANAESTHETIC]; DOG: [PRE-ANAESTHETIC]; HORSE: [PRE-ANAESTHETIC]; PIGS: [PRE-ANAESTHETIC]; For the anaesthetic premedication of dogs, cats, pigs, horses and cattle.
Registered
2023-07-01
ANAMAV ANAESTHETIC PREMEDICANT 37408 / 113498 Product Name: APVMA Approval No: Label Name: ANAMAV ANAESTHETIC PREMEDICANT Signal Headings: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY Constituent Statements: 2 mg/mL ACEPROMAZINE present as 2.7 mg/mL Acepromazine Maleate 0.42 mg/mL ATROPINE present as 1 mg/mL Atropine Sulphate Claims: For the anaesthetic premedication of Dogs, Cats, Pigs, Horses and Cattle. Net Contents: 100 mL Directions for Use: Restraints: Contraindications: Precautions: Side Effects: Dosage and Administration: Administer by intravenous or subcutaneous injection. Dosage Guide: Dogs and Cats: 0.5 - 1 mL/ 10 kg bodyweight Pigs: 0.25 - 5 mL/ 10 kg bodyweight Horses and Cattle: 2.5 - 5 mL/ 100 kg bodyweight RLP APPROVED General Directions: Withholding Periods: Trade Advice: Safety Directions: First Aid Instructions: If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131126. First Aid Warnings: Additional User Safety: Environmental Statements: Disposal: Dispose of container by wrapping with paper and putting in garbage. Storage: Store below 30 ˚C (room temperature). Protect from light. Lue koko asiakirja
MAVLAB Chemwatch Hazard Alert Code: 2 ANAMAV ANAESTHETIC PREMEDICANT (ANAMAV ANAESTHETIC PREMEDICANT) Chemwatch: 34-9544 Version No: 4.1.1.1 Safety Data Sheet according to WHS and ADG requirements Issue Date: 30/03/2017 Print Date: 25/07/2018 L.GHS.AUS.EN.RISK SECTION 1 IDENTIFICATION OF THE SUBSTANCE / MIXTURE AND OF THE COMPANY / UNDERTAKING PRODUCT IDENTIFIER PRODUCT NAME Anamav Anaesthetic Premedicant (Anamav Anaesthetic Premedicant) SYNONYMS Manufacturer's Code: P0700 OTHER MEANS OF IDENTIFICATION Not Available RELEVANT IDENTIFIED USES OF THE SUBSTANCE OR MIXTURE AND USES ADVISED AGAINST RELEVANT IDENTIFIED USES Anaesthetic premedication and tranquillisation of cats, dogs, equine and pigs. Veterinary chemical products at the point of administration to animals are excluded from the scope of the Workplace Health and Safety regulations DETAILS OF THE SUPPLIER OF THE SAFETY DATA SHEET REGISTERED COMPANY NAME MAVLAB ADDRESS 33 Rowland St Slacks Creek QLD 4127 Australia TELEPHONE +61 7 3808 1399 FAX +61 7 3808 4328 WEBSITE www.mavlab.com.au EMAIL info@mavlab.com.au EMERGENCY TELEPHONE NUMBER ASSOCIATION / ORGANISATION NOT AVAILABLE EMERGENCY TELEPHONE NUMBERS Not Available OTHER EMERGENCY TELEPHONE NUMBERS Not Available CHEMWATCH EMERGENCY RESPONSE PRIMARY NUMBER ALTERNATIVE NUMBER 1 ALTERNATIVE NUMBER 2 1800 039 008 1800 039 008 +612 9186 1132 ONCE CONNECTED AND IF THE MESSAGE IS NOT IN YOUR PREFERED LANGUAGE THEN PLEASE DIAL 01 SECTION 2 HAZARDS IDENTIFICATION CLASSIFICATION OF THE SUBSTANCE OR MIXTURE HAZARDOUS CHEMICAL. NON-DANGEROUS GOODS. ACCORDING TO THE WHS REGULATIONS AND THE ADG CODE. CHEMWATCH HAZARD RATINGS Max Min Flammability 0 Toxicity 2 Body Contact 2 Reactivity 0 Chronic 2 0 = Minimum 1 = Low 2 = Moderate 3 = High 4 = Extreme POISONS SCHEDULE S4 CLASSIFICATION [1] Acute Toxicity (Oral) Category 4, Acute Toxicity (Dermal) Category 4, Acute Toxicity (Inhalation) Category 4, Skin Sensitizer Category 1 _*LIMITED EVIDENCE_ _LEGEND:_ _1. Classified by Chemwatch; 2. Classification drawn from HSIS; 3. Cla Lue koko asiakirja